• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
layoffs cuts workforce reduction chairs boxes fired
Biotech

Biopharma layoffs maintain slowdown in Q1

Have we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the figures.
James Waldron Apr 1, 2026 8:42am
US currency next to a ruler pen and calculator

Top 10 pharma R&D budgets of 2025

Mar 30, 2026 3:00am
Fierce Biotech43png

Scaling Radioligand Therapy: Expanding the Impact of Theranostics

Brought to you by Curium
concept of two individuals in a dispute

In deal fraud dispute with Novo, KBP looks to revive heart drug

Apr 1, 2026 2:30am
cancelled flights

Gilead cancels HIV trial as clinical hold remains intact

Apr 1, 2026 4:50pm
Valneva

Why Valneva CEO remains bullish on Pfizer-partnered Lyme vaccine

Apr 1, 2026 3:00pm
More News

Drug combo treats cancers with ‘paradox’ mutation in mice

Apr 1, 2026 2:00pm

Thousands of trial sites impacted by Middle East war: report

Apr 1, 2026 1:03pm

Alzheimer's-focused Korsana uses Cyclerion merger to go public

Apr 1, 2026 9:54am

Oric chases Pfizer into phase 3 hailing prostate cancer edge

Apr 1, 2026 9:53am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings